Magnetic and Fluorescent Dual-Labeled Genetically Encoded Targeted Nanoparticles for Malignant Glioma Cell Tracking and Drug Delivery

Human glioblastoma multiforme (GBM) is a primary malignant brain tumor, a radically incurable disease characterized by rapid growth resistance to classical therapies, with a median patient survival of about 15 months. For decades, a plethora of approaches have been developed to make GBM therapy more...

Descripción completa

Detalles Bibliográficos
Autores principales: Gabashvili, Anna N., Chmelyuk, Nelly S., Oda, Vera V., Leonova, Maria K., Sarkisova, Viktoria A., Lazareva, Polina A., Semkina, Alevtina S., Belyakov, Nikolai A., Nizamov, Timur R., Nikitin, Petr I.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609955/
https://www.ncbi.nlm.nih.gov/pubmed/37896182
http://dx.doi.org/10.3390/pharmaceutics15102422

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10609955/
https://www.ncbi.nlm.nih.gov/pubmed/37896182
http://dx.doi.org/10.3390/pharmaceutics15102422

Ejemplares similares